TD Cowen Maintains Hold on BioNTech, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Werber maintains a Hold rating on BioNTech (NASDAQ:BNTX) but lowers the price target from $98 to $85.
August 06, 2024 | 4:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TD Cowen analyst Yaron Werber maintains a Hold rating on BioNTech but lowers the price target from $98 to $85.
The lowered price target from $98 to $85 suggests a less optimistic outlook for BioNTech's stock performance, which could lead to a short-term decline in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100